Cholesterol metabolism and pancreatic β-cell function

Current Opinion in Lipidology

Volumn 20, Issue 3, 2009, Pages 159-164

  Fryirs, Michelle ^a   Barter, Philip J ^a,b   Rye, Kerry Anne ^a,b,c,d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b University of Sydney   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d HEART RESEARCH INSTITUTE   (Australia)

Author keywords

cell; ABCA1; Cholesterol homeostasis; Insulin; Lipoproteins

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; CARRIER PROTEIN; CELL SURFACE RECEPTOR; GLITAZONE DERIVATIVE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; VERY LOW DENSITY LIPOPROTEIN;

CELL SURVIVAL; CELL VIABILITY; CHOLESTEROL METABOLISM; DIABETES MELLITUS; DRUG MECHANISM; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CHOLESTEROL; DIABETES MELLITUS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; LIPOPROTEINS;

EID: 67049155954     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOL.0b013e32832ac180     Document Type: Review

References (26)

1. Poitout V, Robertson RP. Glucolipotoxicity: fuel excess and beta-cell dysfunc- tion. Endocr Rev 2008; 29:351-366. This review documents current knowledge of the mechanisms of fatty acid-induced β-cell toxicity.
2. Brunham LR, Kruit JK, Pape TD, et al. Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment. Nat Med 2007; 13:340-347. This study shows that ABCA1 is highly expressed in β-cells and is important for maintaining normal insulin secretion. It also highlights the importance of ABCA1 in the action of thiazolidinediones.
3. Hao M, Head WS, Gunawardana SC, et al. Direct effect of cholesterol on insulin secretion: a novel mechanism for pancreatic beta-cell dysfunction. Diabetes 2007; 56:2328-2338. This article describes the deleterious effects of β-cell cholesterol accumulation on insulin secretion. It shows that excess cholesterol inhibits glucokinase activity, decreases glycolysis and reduces insulin secretion. These effects were alleviated by depleting the β-cells of cholesterol.
4. Ishikawa M, Iwasaki Y, Yatoh S, et al. Cholesterol accumulation and diabetes in pancreatic {beta}-cell-specific SREBP-2 transgenic mice: a new model for lipotoxicity. J Lipid Res 2008; 49:2524-2534. In this study, overexpression of human SREBP-2 increased β-cell cholesterol, decreased β-cell mass and produced a diabetic phenotype.
5. Gerin I, Dolinsky VW, Shackman JG, et al. LXRbeta is required for adipocyte growth, glucose homeostasis, and beta cell function. J Biol Chem 2005; 280:23024-23031.
6. Ginsberg HN. Diabetic dyslipidemia: basic mechanisms underlying the common hypertriglyceridemia and low HDL cholesterol levels. Diabetes 1996; 45 (Suppl 3):S27-S30.
7. Murao K, Wada Y, Nakamura T, et al. Effects of glucose and insulin on rat apolipoprotein A-l gene expression. J Biol Chem 1998; 273:18959-18965.
8. Cummings MH, Watts GF, Umpleby AM, et al. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM. Diabetologia 1995; 38:959-967.
9. Sniderman AD, Scantlebury T, Cianflone K. Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes meliitus. Ann Intern Med 2001; 135:447-459.
10. Reaven GM, Chen YD, Jeppesen J, et al. Insulin resistance and hyperinsu-linemia in individuals with small, dense low density lipoprotein particles. J Clin Invest 1993; 92:141-146.
11. Xia F, Gao X, Kwan E, et al. Disruption of pancreatic beta-cell lipid rafts modifies Kv2.1 channel gating and insulin exocytosis. J Biol Chem 2004; 279:24685-24691.
12. Vikman J, Jimenez-Feltstrom J, Nyman P, et al. Insulin secretion is highly sensitive to desorption of plasma membrane cholesterol. FASEB J 2009; 23:58-67.
13. Xia F, Xie L, Mihic A, et al. Inhibition of cholesterol biosynthesis impairs insulin secretion and voltage-gated calcium channel function in pancreatic beta-cells. Endocrinology 2008; 149:5136-5145.
14. Rizzo MA, Piston DW. Regulation of beta cell glucokinase by S-nitrosylation and association with nitric oxide synthase. J Cell Biol 2003; 161:243-248.
15. Wiser O, Trus M, Hernandez A, et al. The voltage sensitive Lc-type Ca2+ channel is functionally coupled to the exocytotic machinery. Proc Natl Acad Sci U S A 1999; 96:248-253.
16. Larsson S, Wierup N, Sundler F, et al. Lack of cholesterol mobilization in islets of hormone-sensitive lipase deficient mice impairs insulin secretion. Biochem Biophys Res Commun 2008; 376:558-562.
17. Cavaghan MK, Ehrmann DA, Byrne MM, Polonsky KS. Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance. J Clin Invest 1997; 100:530-537.
18. Higa M, Zhou YT, Ravazzola M, et al. Troglitazone prevents mitochondrial alterations, beta cell destruction, and diabetes in obese prediabetic rats. Proc Natl Acad Sci U S A 1999; 96:11513-11518.
19. Frikke-Schmidt R, Nordestgaard BG, Schnohr P, et al. Mutation in ABCA1 predicted risk of ischemic heart disease in the Copenhagen City Heart Study Population. J Am Coll Cardiol 2005; 46:1516-1520.
20. Daimon M, Kido T, Baba M, et al. Association of the ABCA1 gene polymorphisms with type 2 DM in a Japanese population. Biochem Biophys Res Commun 2005; 329:205-210.
21. Villarreal-Molina MT, Aguilar-Salinas CA, Rodriguez-Cruz M, et al. The ATP-binding cassette transporter A1 R230C variant affects HDL cholesterol levels and BMI in the Mexican population: association with obesity and obesity-related comorbidities. Diabetes 2007; 56:1881-1887.
22. Passarelli M, Tang C, McDonald TO, et al. Advanced glycation end product precursors impair ABCA1-dependent cholesterol removal from cells. Diabetes 2005; 54:2198-2205.
23. Sartipy P, Loskutoff DJ. Expression profiling identifies genes that continue to respond to insulin in adipocytes made insulin-resistant by treatment with tumor necrosis factor-alpha. J Biol Chem 2003; 278:52298-52306.
24. Choe SS, Choi AH, Lee JW, et al. Chronic activation of liver X receptor induces beta-cell apoptosis through hyperactivation of lipogenesis: liver X receptor-mediated lipotoxicity in pancreatic beta-cells. Diabetes 2007; 56:1534-1543.
25. Roehrich ME, Mooser V, Lenain V, et al. Insulin-secreting beta-cell dysfunction induced by human lipoproteins. J Biol Chem 2003; 278:18368-18375.
26. Abderrahmani A, Niederhauser G, Favre D, et al. Human high-density lipo- protein particles prevent activation of the JNK pathway induced by human oxidised low-density lipoprotein particles in pancreatic beta cells. Diabetolo-gia 2007; 50:1304-1314.